Indication and Usage: LEXIVA is indicated in combination with other antiretroviral agents for the treatment of HIV infection. The PI-experienced–patient study was not large enough to reach a definitive conclusion that LEXIVA/ritonavir and lopinavir/ritonavir are clinically equivalent. Once-daily administration of LEXIVA plus ritonavir is not recommended for PI-experienced patients or any pediatric patients. LEXIVA does not cure HIV or prevent passing HIV to others.
Important Safety Information: You should not take LEXIVA if you have had an allergic reaction to LEXIVA or AGENERASE® (amprenavir). You should not take LEXIVA with: AGENERASE® (amprenavir), Halcion® (triazolam), ergot medications (Cafergot®, Migranal®, D.H.E. 45®, and others), Propulsid® (cisapride), CONTINUED BELOW
With family and friends in your corner, you're committed to this regimen.
LEXIVA is often taken with another HIV medicine called Norvir® (ritonavir). Norvir boosts the effect of LEXIVA by making it last longer in the body. If you have never taken a protease inhibitor before, LEXIVA can be taken with half of the usual dose of Norvir—100 mg (1 pill) instead of 200 mg (2 pills).
You might be able to take LEXIVA with Norvir just once a day. It depends on several factors, including your age,
if you have liver disease, and whether or not you have taken a protease inhibitor before:

2 LEXIVA (700 mg tablets) and 1 Norvir (100 mg capsule), once daily
You can also take:
You can take 1 LEXIVA (700 mg tablet) plus 1 Norvir (100 mg capsule), twice daily

With the exception of LEXIVA, the products mentioned on this page are not trademarks of ViiV Healthcare.
The makers of these brands are not affiliated with and do not endorse ViiV Healthcare.
Talk to your doctor to see if LEXIVA is right for you.
Please see the full Prescribing Information for LEXIVA.
LEXIVA is indicated in combination with other antiretroviral agents for the treatment of HIV infection.
LEXIVA does not cure HIV or prevent passing HIV to others.